IFNG and tuberculosis: Initial studies with non-tuberculosis mycobacteria-infected patients (atypical pulmonary mycobacteriosis), showed that IFNγ treatment in combination with standard anti-mycobacterial chemotherapy had no impact on sputum cultures, but a pronounced effect in treatment completion rates and decreased lung lesion severity were observed (88).